LataMed AI Corp.

LMEDdata completeness 75%3 fiscal years on file

Data notes: no data for concept 'capex'; no data for concept 'totalDebt'

i. The business — what you’d actually own

Figure	FY 2023	FY 2024	FY 2025
Revenue	$0¹	$0²	$0²
Net income	−$1.73M³	−$3.26M⁴	−$207,485⁴
Operating cash flow	−$70,301⁵	−$66,834⁶	−$205,791⁶
Capital expenditure	—	—	—
Free cash flow (derived)	—	—	—
Total debt	—	—	—
Cash & equivalents	$0⁷	$0⁷	$0⁷
Diluted shares	88.9M	29.3M	44.3M

Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).

ii. Your slice — ownership made literal

If you owned

Net assets behind them

−$0.14

your share of equity

Profit it earned you last year

−$0.05

Free cash flow it threw off

—

Debt you’d be carrying

—

10 shares is a claim on −$0.14 of net worth that earned you −$0.05 last year.

iii. Is this a good business?

Moat signal · return on equity

— avg · 3y

Not enough data in the filings for a return-on-capital reading.

Management signal · capital allocation

−50% shares · 3y

Share count is down 50% over 3 years — management has been buying back stock, quietly handing owners a bigger slice.

Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.

iv. What it’s worth — engine v0.1.0

DCF · Growth Exit 10Y

not applicable

only 0 years of FCF (need ≥3) — model not applicable

DCF · Growth Exit 5Y

not applicable

only 0 years of FCF (need ≥3) — model not applicable

Earnings Power Value

not applicable

normalized (5y-median) earnings non-positive — EPV undefined

Graham Number

not applicable

diluted EPS missing or non-positive — Graham Number undefined

Different models answer different questions — which to trust when →

Sources — the receipts